R 1204
Latest Information Update: 25 Jul 2006
At a glance
- Originator Roche
- Class
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder
Most Recent Events
- 25 Jul 2006 No development reported - Phase-I for Anxiety disorders in Europe (unspecified route)
- 25 Jul 2006 No development reported - Phase-I for Depression in Europe (unspecified route)
- 17 Mar 2003 Phase-I clinical trials in Anxiety disorders in Europe (unspecified route)